Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric Paul Wehrenberg-Klee, M.D.

Concepts (130)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Yttrium Radioisotopes62021932.550 Why?
Carcinoma, Hepatocellular8202122141.530 Why?
Cryosurgery420244531.200 Why?
Liver Neoplasms10202142531.140 Why?
Embolization, Therapeutic6202113920.790 Why?
Chemoembolization, Therapeutic120211290.740 Why?
Immunotherapy8202444450.710 Why?
Cancer Vaccines1202210230.500 Why?
Radiography, Interventional2201910950.500 Why?
Positron-Emission Tomography8202162340.480 Why?
Granzymes320202710.450 Why?
Neoplasms, Experimental1201612760.370 Why?
Molecular Imaging120168280.330 Why?
Receptor, erbB-3220211420.330 Why?
Neoplasms52024216830.320 Why?
Receptor Protein-Tyrosine Kinases1201616600.320 Why?
Patient Selection2201942150.300 Why?
Combined Modality Therapy5202486420.290 Why?
Catheter Ablation3202127580.280 Why?
Microspheres320217770.240 Why?
Glycolates12023400.240 Why?
Portal Pressure12020620.190 Why?
Adjuvants, Immunologic2202310000.190 Why?
Radiation Pneumonitis120201040.180 Why?
Technology120223050.180 Why?
Radiopharmaceuticals2202026450.180 Why?
Tissue Distribution2202123270.170 Why?
Liver Transplantation2202121190.170 Why?
Kidney Failure, Chronic1201125380.170 Why?
Genes, cdc120181160.160 Why?
Hypertension, Portal120202200.160 Why?
Kidney Neoplasms2201342620.160 Why?
Antineoplastic Agents12021136950.160 Why?
Ablation Techniques120212490.150 Why?
Cell Line, Tumor62021166890.150 Why?
Liver Function Tests120195280.150 Why?
Safety1202111860.140 Why?
Carcinoma, Renal Cell1201131430.140 Why?
Immunologic Factors2202215800.140 Why?
Angiography1202016390.130 Why?
Hepatectomy120185500.120 Why?
Quinazolines1202113560.120 Why?
Salvage Therapy1202112750.120 Why?
Breast Neoplasms12021208220.120 Why?
Treatment Outcome102021631140.110 Why?
Octreotide120131450.110 Why?
Receptors, Somatostatin120131290.110 Why?
Brachytherapy1202112480.110 Why?
Radiotherapy Dosage1201928790.100 Why?
Receptor, erbB-21202124160.100 Why?
Lung2202098560.100 Why?
Humans2420247443430.100 Why?
Intestinal Neoplasms120133190.100 Why?
Colonic Neoplasms2201825410.090 Why?
Lymphoma1201818770.090 Why?
Neuroendocrine Tumors120135940.080 Why?
Tomography, X-Ray Computed32018201290.070 Why?
Lymph Nodes1201834740.070 Why?
Mice82021811830.070 Why?
Drug Resistance, Neoplasm1202151720.070 Why?
Peptides1201844090.070 Why?
Gallium Radioisotopes220181780.070 Why?
Antineoplastic Agents, Hormonal1201315240.060 Why?
Hypnotics and Sedatives1201311620.060 Why?
Surgery, Computer-Assisted1201310180.060 Why?
Glomerular Filtration Rate1201121700.060 Why?
Retrospective Studies82021774490.060 Why?
Pain, Postoperative1201316430.050 Why?
Animals820211687570.050 Why?
Cell Proliferation22016104810.050 Why?
Female1020213801940.050 Why?
Technetium Tc 99m Aggregated Albumin12020670.050 Why?
Colorectal Neoplasms1202167730.050 Why?
Sensitivity and Specificity12016147220.050 Why?
Liver Circulation120201640.050 Why?
Male920213501180.050 Why?
Aged, 80 and over52020577760.040 Why?
Microwaves120211910.040 Why?
Retreatment120206100.040 Why?
Antibodies, Monoclonal1201692740.040 Why?
Somatostatin120204590.040 Why?
Melanoma1201755100.040 Why?
Prognosis22016290630.040 Why?
Retroperitoneal Space120181760.040 Why?
Pulmonary Circulation120207390.040 Why?
Reproducibility of Results12016199050.040 Why?
Middle Aged820212133830.040 Why?
Aged720211632800.040 Why?
Biotin120182540.040 Why?
Prospective Studies12021532880.040 Why?
Radiometry120218000.030 Why?
Biomarkers, Pharmacological120171620.030 Why?
Pelvis120187300.030 Why?
Chemical Fractionation12013650.030 Why?
Adult520202140550.030 Why?
Predictive Value of Tests22020150760.030 Why?
Droperidol12013210.030 Why?
Radiation Dosage1202019280.030 Why?
Solubility1201310850.030 Why?
Midazolam120132700.020 Why?
Lymphatic Metastasis1201829240.020 Why?
Liver Cirrhosis1202018630.020 Why?
Contrast Media1202353000.020 Why?
Hemodynamics1202041990.020 Why?
Kaplan-Meier Estimate1202165380.020 Why?
Fentanyl120134100.020 Why?
T-Lymphocytes, Cytotoxic1201718210.020 Why?
Radionuclide Imaging1201320310.020 Why?
Risk Assessment22021233380.020 Why?
Feasibility Studies1201950780.020 Why?
Cohort Studies22021405610.020 Why?
Time Factors22021400750.020 Why?
Tumor Microenvironment1202035860.020 Why?
Mice, Inbred BALB C1201663860.020 Why?
Tumor Burden1201319150.020 Why?
Mice, Nude1201336890.020 Why?
Cell Transformation, Neoplastic1201629420.020 Why?
Protein Binding1201893860.020 Why?
Tumor Cells, Cultured1201363140.020 Why?
Xenograft Model Antitumor Assays1201335570.020 Why?
Biopsy1201767560.020 Why?
Risk Factors22021722900.010 Why?
Pain Measurement1201334200.010 Why?
Dose-Response Relationship, Drug12013109430.010 Why?
Disease Models, Animal12018180290.010 Why?
Follow-Up Studies12021390500.010 Why?
Rats12013242600.010 Why?
Young Adult12018564300.010 Why?
Child12018777090.010 Why?
Adolescent12018857810.010 Why?
Wehrenberg-Klee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.